A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence (opens ClinicalTrials.gov)
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Enrolment
- 222
- Started
- 2026-05-29
- Last update
- 2026-11-03
Conditions: Narcolepsy Type 1, Narcolepsy Type 2
Interventions: cleminorexton, Placebo